Colobreathe European Union - English - EMA (European Medicines Agency)

colobreathe

teva b.v. - colistimethate sodium - cystic fibrosis - antibacterials for systemic use, - colobreathe is indicated for the management of chronic pulmonary infections due to pseudomonas aeruginosa in patients with cystic fibrosis (cf) aged six years and older.consideration should be given to official guidance on the appropriate use of antibacterial agents.

SALBUVENT Nebuliser Solution 2.5/2.5 Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

salbuvent nebuliser solution 2.5/2.5 mg/ml

breathe pharmaceuticals limited - salbutamol sulfate - nebuliser solution - 2.5/2.5 mg/ml

SALBUVENT Nebuliser Solution 5/2.5 Mg/Ml Ireland - English - HPRA (Health Products Regulatory Authority)

salbuvent nebuliser solution 5/2.5 mg/ml

breathe pharmaceuticals limited - salbutamol sulfate - nebuliser solution - 5/2.5 mg/ml

BUDESITAN 0.5MG/2ML NEBULISER SUSPENSION Ireland - English - HPRA (Health Products Regulatory Authority)

budesitan 0.5mg/2ml nebuliser suspension

breathe pharmaceuticals limited - budesonide - nebuliser suspension - 0.5mg/2ml

BUDESITAN 1.0MG/2ML NEBULISER SUSPENSION Ireland - English - HPRA (Health Products Regulatory Authority)

budesitan 1.0mg/2ml nebuliser suspension

breathe pharmaceuticals limited - budesonide - nebuliser suspension - 1.0mg/2ml

COMBINEB Nebuliser Solution 0.5mg/2.5m Milligrams per Ampule Ireland - English - HPRA (Health Products Regulatory Authority)

combineb nebuliser solution 0.5mg/2.5m milligrams per ampule

breathe pharmaceuticals limited - ipratropium bromide salbutamol - nebuliser solution - 0.5mg/2.5m milligrams per ampule

IPRAVENT Nebuliser Solution 250mcg/1ml Microgram/ML Ireland - English - HPRA (Health Products Regulatory Authority)

ipravent nebuliser solution 250mcg/1ml microgram/ml

breathe pharmaceuticals limited - ipratropium bromide - nebuliser solution - 250mcg/1ml microgram/ml

IPRAVENT Nebuliser Solution 500mcg/2ml Microgram/ML Ireland - English - HPRA (Health Products Regulatory Authority)

ipravent nebuliser solution 500mcg/2ml microgram/ml

breathe pharmaceuticals limited - ipratropium bromide - nebuliser solution - 500mcg/2ml microgram/ml

Longtec 15 mg prolonged release tablets United Kingdom - English - myHealthbox

longtec 15 mg prolonged release tablets

qdem pharmaceuticals limited - oxycodone as oxycodone hydrochloride. - tablets - 13.5 mg of oxycodone as 15 mg of oxycodone hydrochloride - natural opium alkaloids - for the treatment of moderate to severe pain in patients with cancer and post-operative pain. for the treatment of severe pain requiring the use of a strong opioid.

Longtec 30 mg prolonged release tablets United Kingdom - English - myHealthbox

longtec 30 mg prolonged release tablets

qdem pharmaceuticals limited - oxycodone as oxycodone hydrochloride. - tablets - 27 mg of oxycodone as 30 mg of oxycodone hydrochloride - natural opium alkaloids - for the treatment of moderate to severe pain in patients with cancer and post-operative pain. for the treatment of severe pain requiring the use of a strong opioid.